Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 8701-8750 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06915116
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
PHASE2Recruiting
60 participants
Started: Mar 31, 2025 · Completed: Mar 31, 2027
2 conditions1 sponsor7 locations
NCT06911359
The Effect and Safety of Anti-inflammatories and Dextrose Prolotherapy Injections in Treating Knee Osteoarthritis
PHASE2Recruiting
68 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06933953
Validation of the Foot Health Status Questionnaire in French Language
NARecruiting
150 participants
Started: Mar 31, 2025 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT06820424
Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors
EARLY_PHASE1Recruiting
30 participants
Started: Mar 31, 2025 · Completed: Jun 30, 2028
1 condition2 sponsors1 location
NCT06592638
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
PHASE1Recruiting
30 participants
Started: Mar 31, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor6 locations
NCT06494618
Effects of Botulinum Toxin Injection Combined with RESWT in Lower Extremity Spasticity in Children with Cerebral Palsy
NARecruiting
20 participants
Started: Mar 31, 2025 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06679790
Trajectories of Change in Tourette Syndrome
NARecruiting
30 participants
Started: Mar 31, 2025 · Completed: May 15, 2029
2 conditions1 sponsor1 location
NCT07105787
Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna
NARecruiting
42 participants
Started: Mar 31, 2025 · Completed: Apr 30, 2026
2 conditions3 sponsors2 locations
NCT07004452
Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial
N/ARecruiting
5,000 participants
Started: Mar 31, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06930287
Footwear Difference in Sports Use in Runners With Functional Equinus
N/ARecruiting
20 participants
Started: Mar 31, 2025 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06832410
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
PHASE3Recruiting
10 participants
Started: Mar 31, 2025 · Completed: Sep 17, 2027
2 conditions1 sponsor7 locations
NCT06991023
Prebiotic Effects on Anxiety, Cortisol, and Emotional Processing in Mild-to-Moderately Stressed Adults
NARecruiting
55 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06866613
Phase III Trial to Evaluate the Efficacy and Safety in Patients With Ankle Sprains.
PHASE3Recruiting
69 participants
Started: Mar 31, 2025 · Completed: Oct 31, 2025
1 condition6 sponsors5 locations
NCT06337123
Physica TT Tibial Plate Follow up Study
N/ARecruiting
130 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor3 locations
NCT06803875
Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
PHASE1/PHASE2Recruiting
42 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2029
3 conditions3 sponsors2 locations
NCT07008664
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
N/ARecruiting
750 participants
Started: Mar 31, 2025 · Completed: Apr 30, 2032
4 conditions2 sponsors1 location
NCT06756035
CT-95 in Advanced Cancers Associated With Mesothelin Expression
PHASE1Recruiting
70 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2028
11 conditions1 sponsor8 locations
NCT06946641
A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients
PHASE1Recruiting
102 participants
Started: Mar 31, 2025 · Completed: Apr 30, 2026
3 conditions1 sponsor1 location
NCT06940128
Direct Ischemic Conditioning for Endovascular Recanalization for Anterior Large Vessel Occlusion (DICER-aLVO)
NARecruiting
120 participants
Started: Mar 31, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06807463
A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
PHASE2Recruiting
48 participants
Started: Mar 31, 2025 · Completed: Sep 14, 2027
1 condition1 sponsor16 locations
NCT06820099
Efficacy and Safety of HRS-7535 in for Heart Failure With Preserved Ejection Fraction and Obesity
PHASE2Recruiting
180 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06921486
The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)
PHASE2/PHASE3Recruiting
992 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor13 locations
NCT06466382
OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
NARecruiting
60 participants
Started: Mar 31, 2025 · Completed: Sep 30, 2028
4 conditions2 sponsors4 locations
NCT06064136
Psoas Tenotomy Under Ultrasound
NARecruiting
15 participants
Started: Mar 31, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06627842
OsteoArticular Sepsis in Intensive Care unitS
N/ARecruiting
150 participants
Started: Mar 31, 2025 · Completed: Jul 31, 2025
3 conditions1 sponsor1 location
NCT06882577
Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy
N/ARecruiting
400 participants
Started: Mar 31, 2025 · Completed: Mar 31, 2029
1 condition1 sponsor1 location
NCT06823726
Taekwondo for Axial Spondyloarthritis
NARecruiting
24 participants
Started: Mar 31, 2025 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT06161974
Study of Olutasidenib and Temozolomide in HGG
PHASE2Recruiting
60 participants
Started: Mar 31, 2025 · Completed: Jun 30, 2035
19 conditions2 sponsors18 locations
NCT06337786
Investigating the Effects of the Digital App Rheumabuddy4.1 in a Clinical RCT Set-up in Patients With Rheumatoid Arthritis
NARecruiting
70 participants
Started: Mar 31, 2025 · Completed: Jun 30, 2026
1 condition4 sponsors1 location
NCT06652438
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
PHASE3Recruiting
415 participants
Started: Mar 31, 2025 · Completed: Jul 10, 2031
1 condition3 sponsors67 locations
NCT06470282
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
PHASE1/PHASE2Recruiting
47 participants
Started: Mar 31, 2025 · Completed: Jan 31, 2028
4 conditions3 sponsors1 location
NCT06828393
A Phase 1 Study of S-1117
PHASE1Recruiting
96 participants
Started: Mar 31, 2025 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06885827
Vitamin Mix (B6, B9, B12, And Choline) For Glaucoma Patients
NARecruiting
80 participants
Started: Mar 31, 2025 · Completed: Mar 31, 2027
2 conditions2 sponsors2 locations
NCT06898450
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
PHASE1/PHASE2Recruiting
134 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2031
2 conditions2 sponsors11 locations
NCT06890988
Ending the Epidemic Interventions in the Dental Setting - UH3
NARecruiting
128 participants
Started: Mar 31, 2025 · Completed: Sep 1, 2027
1 condition2 sponsors3 locations
NCT06820164
Lipomas Treated with Subcutaneous Injections of Cooled Sodium Chloride
PHASE1/PHASE2Recruiting
20 participants
Started: Mar 31, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06810557
Brief Behavioral Sleep Intervention for Obesity Prevention in Primary Care
NARecruiting
50 participants
Started: Mar 31, 2025 · Completed: Oct 1, 2026
3 conditions2 sponsors1 location
NCT06856785
Management of Non-Organic Dysphonia in Adults.
NARecruiting
60 participants
Started: Mar 31, 2025 · Completed: Sep 30, 2025
3 conditions1 sponsor1 location
NCT07028762
Evaluation of Catching Skills in Preschoolers With Motor Difficulties
N/ARecruiting
40 participants
Started: Mar 31, 2025 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06693908
A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis
PHASE1/PHASE2Recruiting
24 participants
Started: Mar 31, 2025 · Completed: May 6, 2026
1 condition1 sponsor1 location
NCT07219927
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
N/ARecruiting
120 participants
Started: Mar 31, 2025 · Completed: Aug 1, 2027
1 condition1 sponsor5 locations
NCT06826014
TREC@TAMU Cancer Prevention Registry and Repository
N/ARecruiting
2,500 participants
Started: Mar 31, 2025 · Completed: Nov 30, 2030
5 conditions1 sponsor1 location
NCT06859203
A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PET
N/ARecruiting
94 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT06211400
Vibration Exercise for Crohn's to Observe Response
NARecruiting
168 participants
Started: Mar 31, 2025 · Completed: Jan 1, 2028
1 condition3 sponsors1 location
NCT06225232
Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study
PHASE2Recruiting
16 participants
Started: Mar 31, 2025 · Completed: Jun 30, 2026
2 conditions3 sponsors1 location
NCT05974358
KONO-S Anastomosis Compared to Conventional Ileocolonic Anastomosis to Reduce Recurrence in Crohn's Disease
NARecruiting
226 participants
Started: Mar 31, 2025 · Completed: Feb 28, 2029
1 condition1 sponsor15 locations
NCT06615102
Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II
PHASE3Recruiting
1,022 participants
Started: Mar 31, 2025 · Completed: Apr 30, 2027
2 conditions2 sponsors4 locations
NCT06867198
Peanuts for Cardiometabolic, Brain, and Intestinal Health
NARecruiting
72 participants
Started: Mar 31, 2025 · Completed: Sep 30, 2027
8 conditions3 sponsors1 location
NCT06705790
Exploring the Benefits of Pelvic Floor Muscle Training on Bladder, Bowel, and Sexual Function in People with Spinal Cord Injury
NARecruiting
30 participants
Started: Mar 31, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06980116
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
PHASE1Recruiting
50 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor3 locations